WST West Pharmaceutical Services Inc

  1. Stocks
  2. Healthcare
  3. NYSE: WST

Price (delayed)

$328.2

Market cap

$23.1B

P/E Ratio

41.7

Dividend/share

$0.87

EPS

$7.87

Enterprise value

$22.97B

?
Relative Growth: Rel. Growth: 67
Relative Strength: Rel. Strength: 67
Relative Valuation: Rel. Valuation: 26
Relative Profitability: Rel. Profitability: 78

West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare ...

Highlights
WST's EPS is up by 17% year-on-year and by 4.7% since the previous quarter
The gross profit has grown by 17% YoY and by 4.7% from the previous quarter
The stock's price to earnings (P/E) is 6% more than its last 4 quarters average of 39.5 but 2.1% less than its 5-year quarterly average of 42.6
WST's debt is up by 2.9% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.westpharma.com
Peers: BDX ICUI SYK BAX

Key stats

What are the main financial stats of WST

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
-7.67%
1 week
-8.39%
1 month
-3.59%
1 year
17.59%
YTD
19.28%
QTD
-8.58%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$3.33B
Gross profit
$1.22B
Operating income
$680.4M
Net income
$564.9M
Gross margin
36.8%
Net margin
17%
WST's operating income is up by 17% YoY and by 3.9% from the previous quarter
The gross profit has grown by 17% YoY and by 4.7% from the previous quarter
The net income has grown by 16% YoY and by 4.1% from the previous quarter
West Pharmaceutical Services's revenue has increased by 12% YoY and by 3.3% from the previous quarter

Price vs fundamentals

How does WST's price correlate with its fundamentals

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
WST P/E details
P/E
41.7
P/B
7.75
P/S
6.98
EV/EBIT
32.19
EV/EBITDA
25.67
EV/Sales
6.91
WST's EPS is up by 17% year-on-year and by 4.7% since the previous quarter
The stock's price to earnings (P/E) is 6% more than its last 4 quarters average of 39.5 but 2.1% less than its 5-year quarterly average of 42.6
The price to book (P/B) is 16% higher than the last 4 quarters average of 6.7 but 13% lower than the 5-year quarterly average of 8.9
WST's equity is up by 2.1% year-on-year
The P/S is 15% below the 5-year quarterly average of 8.2 but 7% above the last 4 quarters average of 6.5
West Pharmaceutical Services's revenue has increased by 12% YoY and by 3.3% from the previous quarter

Efficiency

How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is up by 9% year-on-year and by 2.2% since the previous quarter
West Pharmaceutical Services's ROE has increased by 4.5% YoY and by 3.4% from the previous quarter
WST's return on sales is up by 3.9% year-on-year
The company's return on assets rose by 3.8% YoY and by 3% QoQ

Dividends

What is WST's dividend history
Dividend details
DPS
$0.87
Dividend yield
0.27%
Payout ratio
11.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did West Pharmaceutical Services financials performed over time
The total liabilities has increased by 6% year-on-year but it has declined by 3% since the previous quarter
West Pharmaceutical Services's current ratio has increased by 4.1% QoQ
WST's debt is 90% smaller than its equity
The debt to equity has contracted by 9% from the previous quarter
WST's debt is up by 2.9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.